Drug class
Antineoplastic - Immunotherapy, Therapeutic Vaccines
The phrase "Antineoplastic - Immunotherapy, Therapeutic Vaccines" is an administrative and formulary classification used by compendia and payer formularies to categorize active immunotherapies designed to treat existing malignancies rather than prevent infection. Read more about Antineoplastic - Immunotherapy, Therapeutic Vaccines
1 drugs in this class 1 manufacturers
Drugs in Antineoplastic - Immunotherapy, Therapeutic Vaccines
The phrase "Antineoplastic - Immunotherapy, Therapeutic Vaccines" is an administrative and formulary classification used by compendia and payer formularies to categorize active immunotherapies designed to treat existing malignancies rather than prevent infection.
Agents in this class work by exposing antigen-presenting cells to tumor-associated antigens or neoantigens, stimulating a targeted, systemic host immune response characterized by the proliferation of cytotoxic T lymphocytes directed against tumor cells.
The primary clinical example is autologous cellular immunotherapy, such as sipuleucel-T, indicated for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.
Research across oncology also actively investigates therapeutic cancer vaccines in modalities spanning peptide, dendritic cell, and nucleic acid platforms for advanced solid tumors and recurrent hematologic diseases.
-
memorialcareselecthealthplan.org
The phrase "Antineoplastic - Immunotherapy, Therapeutic Vaccines" is an administrative and formulary classification used by compendia and payer formularies to categorize active immunotherapies designed to treat existing malignancies rather than prevent infection The primary clinical example is autologous cellular immunotherapy, such as sipuleucel-T, indicated for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer
-
mdpi.com
The phrase "Antineoplastic - Immunotherapy, Therapeutic Vaccines" is an administrative and formulary classification used by compendia and payer formularies to categorize active immunotherapies designed to treat existing malignancies rather than prevent infection The primary clinical example is autologous cellular immunotherapy, such as sipuleucel-T, indicated for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer
-
nih.gov
Agents in this class work by exposing antigen-presenting cells to tumor-associated antigens or neoantigens, stimulating a targeted, systemic host immune response characterized by the proliferation of cytotoxic T lymphocytes directed against tumor cells Research across oncology also actively investigates therapeutic cancer vaccines in modalities spanning peptide, dendritic cell, and nucleic acid platforms for advanced solid tumors and recurrent hematologic diseases
-
nih.gov
Agents in this class work by exposing antigen-presenting cells to tumor-associated antigens or neoantigens, stimulating a targeted, systemic host immune response characterized by the proliferation of cytotoxic T lymphocytes directed against tumor cells Research across oncology also actively investigates therapeutic cancer vaccines in modalities spanning peptide, dendritic cell, and nucleic acid platforms for advanced solid tumors and recurrent hematologic diseases
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.